Concepts (183)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Wounds, Nonpenetrating | 3 | 2016 | 105 | 1.300 |
Why?
|
| Laparoscopy | 8 | 2025 | 455 | 0.790 |
Why?
|
| Pancreas | 2 | 2016 | 148 | 0.600 |
Why?
|
| Abdominal Injuries | 1 | 2016 | 29 | 0.510 |
Why?
|
| Fundoplication | 2 | 2025 | 25 | 0.430 |
Why?
|
| Infant | 11 | 2025 | 1553 | 0.400 |
Why?
|
| Wounds, Penetrating | 1 | 2012 | 26 | 0.380 |
Why?
|
| Child, Preschool | 11 | 2025 | 1891 | 0.360 |
Why?
|
| Child | 15 | 2025 | 4366 | 0.360 |
Why?
|
| Spleen | 1 | 2012 | 480 | 0.350 |
Why?
|
| Retrospective Studies | 17 | 2025 | 6399 | 0.340 |
Why?
|
| Vesico-Ureteral Reflux | 1 | 2009 | 14 | 0.330 |
Why?
|
| Dextrans | 1 | 2009 | 44 | 0.320 |
Why?
|
| Hernia, Inguinal | 2 | 2022 | 41 | 0.320 |
Why?
|
| Prostheses and Implants | 1 | 2009 | 70 | 0.320 |
Why?
|
| Hyaluronic Acid | 1 | 2009 | 67 | 0.310 |
Why?
|
| Herniorrhaphy | 3 | 2025 | 68 | 0.310 |
Why?
|
| Intestinal Obstruction | 2 | 2012 | 53 | 0.300 |
Why?
|
| Appendicitis | 3 | 2018 | 78 | 0.290 |
Why?
|
| Treatment Outcome | 14 | 2025 | 5497 | 0.280 |
Why?
|
| Gastroesophageal Reflux | 2 | 2025 | 91 | 0.280 |
Why?
|
| Digestive System Abnormalities | 1 | 2007 | 3 | 0.280 |
Why?
|
| Infant, Newborn | 6 | 2025 | 1320 | 0.270 |
Why?
|
| Internship and Residency | 3 | 2024 | 772 | 0.270 |
Why?
|
| Adolescent | 11 | 2025 | 6060 | 0.270 |
Why?
|
| Postoperative Complications | 6 | 2025 | 1244 | 0.270 |
Why?
|
| Intestinal Diseases | 1 | 2007 | 34 | 0.260 |
Why?
|
| Digestive System Surgical Procedures | 1 | 2007 | 87 | 0.260 |
Why?
|
| Injury Severity Score | 2 | 2016 | 103 | 0.250 |
Why?
|
| Histamine H2 Antagonists | 1 | 2025 | 15 | 0.240 |
Why?
|
| Hernia, Umbilical | 1 | 2025 | 7 | 0.240 |
Why?
|
| Proton Pump Inhibitors | 1 | 2025 | 42 | 0.240 |
Why?
|
| Gift Giving | 1 | 2024 | 8 | 0.230 |
Why?
|
| Female | 21 | 2025 | 31953 | 0.220 |
Why?
|
| Appendix | 2 | 2018 | 15 | 0.220 |
Why?
|
| Meckel Diverticulum | 1 | 2003 | 3 | 0.210 |
Why?
|
| Humans | 29 | 2025 | 61707 | 0.210 |
Why?
|
| Tomography, X-Ray Computed | 4 | 2018 | 1564 | 0.210 |
Why?
|
| Male | 18 | 2025 | 28947 | 0.200 |
Why?
|
| Pyloric Stenosis | 1 | 2002 | 4 | 0.200 |
Why?
|
| Bronchial Hyperreactivity | 1 | 2002 | 25 | 0.200 |
Why?
|
| Fetal Diseases | 1 | 2002 | 21 | 0.200 |
Why?
|
| Interviews as Topic | 1 | 2024 | 496 | 0.190 |
Why?
|
| Chemoembolization, Therapeutic | 1 | 2002 | 11 | 0.190 |
Why?
|
| Ultrasonography, Prenatal | 1 | 2002 | 42 | 0.190 |
Why?
|
| Hepatoblastoma | 1 | 2002 | 8 | 0.190 |
Why?
|
| Anesthesia, Spinal | 1 | 2022 | 30 | 0.190 |
Why?
|
| General Surgery | 1 | 2024 | 200 | 0.190 |
Why?
|
| Cisplatin | 1 | 2002 | 125 | 0.190 |
Why?
|
| Doxorubicin | 1 | 2002 | 99 | 0.190 |
Why?
|
| Femoral Artery | 1 | 2002 | 110 | 0.180 |
Why?
|
| Education, Medical, Graduate | 2 | 2024 | 333 | 0.180 |
Why?
|
| Suture Techniques | 2 | 2019 | 97 | 0.170 |
Why?
|
| Renal Dialysis | 1 | 2002 | 196 | 0.170 |
Why?
|
| Length of Stay | 4 | 2015 | 791 | 0.170 |
Why?
|
| Liver Neoplasms | 1 | 2002 | 285 | 0.160 |
Why?
|
| Blood Vessel Prosthesis Implantation | 1 | 2002 | 306 | 0.150 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2002 | 427 | 0.150 |
Why?
|
| Educational Measurement | 1 | 2019 | 215 | 0.140 |
Why?
|
| Ultrasonography | 1 | 2018 | 464 | 0.130 |
Why?
|
| Multivariate Analysis | 2 | 2015 | 920 | 0.130 |
Why?
|
| Thoracic Injuries | 1 | 2016 | 46 | 0.130 |
Why?
|
| Follow-Up Studies | 4 | 2025 | 2418 | 0.120 |
Why?
|
| Databases, Factual | 2 | 2015 | 842 | 0.120 |
Why?
|
| Logistic Models | 2 | 2015 | 1265 | 0.120 |
Why?
|
| Clinical Competence | 1 | 2019 | 703 | 0.110 |
Why?
|
| Pectus Carinatum | 1 | 2014 | 4 | 0.110 |
Why?
|
| Braces | 1 | 2014 | 10 | 0.110 |
Why?
|
| Child Advocacy | 1 | 2013 | 6 | 0.110 |
Why?
|
| Wounds, Gunshot | 1 | 2013 | 55 | 0.100 |
Why?
|
| Tissue Adhesions | 1 | 2012 | 19 | 0.100 |
Why?
|
| Firearms | 1 | 2013 | 62 | 0.100 |
Why?
|
| Splenectomy | 1 | 2012 | 41 | 0.100 |
Why?
|
| Enterocolitis, Pseudomembranous | 1 | 2012 | 34 | 0.100 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2014 | 285 | 0.090 |
Why?
|
| Hospital Mortality | 2 | 2013 | 857 | 0.090 |
Why?
|
| Bites and Stings | 1 | 2011 | 11 | 0.090 |
Why?
|
| Facial Injuries | 1 | 2011 | 13 | 0.090 |
Why?
|
| Appendectomy | 2 | 2018 | 52 | 0.090 |
Why?
|
| Wound Infection | 1 | 2011 | 28 | 0.090 |
Why?
|
| Cicatrix | 1 | 2011 | 59 | 0.090 |
Why?
|
| Colectomy | 1 | 2012 | 108 | 0.090 |
Why?
|
| Sutures | 2 | 2016 | 40 | 0.090 |
Why?
|
| Soft Tissue Infections | 1 | 2011 | 49 | 0.090 |
Why?
|
| Community-Acquired Infections | 1 | 2011 | 91 | 0.090 |
Why?
|
| Methicillin-Resistant Staphylococcus aureus | 1 | 2011 | 65 | 0.090 |
Why?
|
| Dogs | 1 | 2011 | 324 | 0.080 |
Why?
|
| Staphylococcal Infections | 1 | 2011 | 127 | 0.080 |
Why?
|
| Retreatment | 1 | 2009 | 47 | 0.080 |
Why?
|
| Cohort Studies | 2 | 2012 | 2500 | 0.080 |
Why?
|
| Laparoscopes | 1 | 2007 | 25 | 0.070 |
Why?
|
| Touch | 1 | 2007 | 27 | 0.070 |
Why?
|
| Cardiovascular Abnormalities | 1 | 2007 | 33 | 0.070 |
Why?
|
| Task Performance and Analysis | 1 | 2007 | 126 | 0.070 |
Why?
|
| Intussusception | 1 | 2006 | 14 | 0.060 |
Why?
|
| Surveys and Questionnaires | 2 | 2024 | 2616 | 0.060 |
Why?
|
| Cellulose, Oxidized | 1 | 2005 | 2 | 0.060 |
Why?
|
| Paraplegia | 1 | 2005 | 7 | 0.060 |
Why?
|
| Umbilicus | 1 | 2025 | 16 | 0.060 |
Why?
|
| Spinal Cord Compression | 1 | 2005 | 29 | 0.060 |
Why?
|
| Operative Time | 1 | 2025 | 87 | 0.060 |
Why?
|
| Reoperation | 1 | 2025 | 286 | 0.060 |
Why?
|
| Thoracoscopy | 1 | 2004 | 25 | 0.050 |
Why?
|
| Personnel Selection | 1 | 2024 | 53 | 0.050 |
Why?
|
| Chi-Square Distribution | 2 | 2016 | 413 | 0.050 |
Why?
|
| Pain, Postoperative | 1 | 2025 | 157 | 0.050 |
Why?
|
| Comorbidity | 1 | 2007 | 1102 | 0.050 |
Why?
|
| Intestine, Small | 1 | 2003 | 79 | 0.050 |
Why?
|
| Hypertrophy | 1 | 2002 | 30 | 0.050 |
Why?
|
| Life Tables | 1 | 2002 | 23 | 0.050 |
Why?
|
| Ligation | 1 | 2022 | 34 | 0.050 |
Why?
|
| Polytetrafluoroethylene | 1 | 2002 | 18 | 0.050 |
Why?
|
| Prosthesis-Related Infections | 1 | 2002 | 34 | 0.050 |
Why?
|
| Vascular Patency | 1 | 2002 | 138 | 0.050 |
Why?
|
| Educational Status | 1 | 2022 | 271 | 0.050 |
Why?
|
| Preoperative Care | 1 | 2002 | 184 | 0.040 |
Why?
|
| Odds Ratio | 2 | 2013 | 764 | 0.040 |
Why?
|
| Blood Vessel Prosthesis | 1 | 2002 | 220 | 0.040 |
Why?
|
| Formative Feedback | 1 | 2019 | 8 | 0.040 |
Why?
|
| Equipment and Supplies | 1 | 2019 | 19 | 0.040 |
Why?
|
| Self-Assessment | 1 | 2019 | 59 | 0.040 |
Why?
|
| Video Recording | 1 | 2019 | 128 | 0.040 |
Why?
|
| Lung | 1 | 2004 | 931 | 0.040 |
Why?
|
| Cross-Sectional Studies | 2 | 2018 | 2491 | 0.040 |
Why?
|
| Incidence | 2 | 2013 | 1330 | 0.040 |
Why?
|
| Age Factors | 2 | 2013 | 1542 | 0.040 |
Why?
|
| Pandemics | 1 | 2022 | 655 | 0.040 |
Why?
|
| Guinea Pigs | 1 | 2016 | 82 | 0.030 |
Why?
|
| Severity of Illness Index | 2 | 2012 | 1523 | 0.030 |
Why?
|
| Random Allocation | 1 | 2016 | 192 | 0.030 |
Why?
|
| Wound Healing | 1 | 2016 | 183 | 0.030 |
Why?
|
| Curriculum | 1 | 2019 | 582 | 0.030 |
Why?
|
| Pregnancy | 1 | 2002 | 2278 | 0.030 |
Why?
|
| Massachusetts | 1 | 2019 | 2049 | 0.030 |
Why?
|
| Pilot Projects | 1 | 2016 | 965 | 0.030 |
Why?
|
| Ovarian Cysts | 1 | 2012 | 4 | 0.020 |
Why?
|
| Hospital Charges | 1 | 2012 | 22 | 0.020 |
Why?
|
| Urban Population | 1 | 2013 | 188 | 0.020 |
Why?
|
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2012 | 47 | 0.020 |
Why?
|
| Young Adult | 2 | 2013 | 4538 | 0.020 |
Why?
|
| Neutropenia | 1 | 2012 | 65 | 0.020 |
Why?
|
| Survival Analysis | 1 | 2013 | 566 | 0.020 |
Why?
|
| Confidence Intervals | 1 | 2012 | 242 | 0.020 |
Why?
|
| Patient Compliance | 1 | 2014 | 356 | 0.020 |
Why?
|
| Soft Tissue Injuries | 1 | 2011 | 20 | 0.020 |
Why?
|
| Unnecessary Procedures | 1 | 2011 | 44 | 0.020 |
Why?
|
| Adult | 2 | 2024 | 16361 | 0.020 |
Why?
|
| Antibiotic Prophylaxis | 1 | 2011 | 54 | 0.020 |
Why?
|
| Regression Analysis | 1 | 2012 | 491 | 0.020 |
Why?
|
| Operating Rooms | 1 | 2011 | 55 | 0.020 |
Why?
|
| Poverty | 1 | 2013 | 295 | 0.020 |
Why?
|
| Emergencies | 1 | 2011 | 115 | 0.020 |
Why?
|
| Socioeconomic Factors | 1 | 2013 | 765 | 0.020 |
Why?
|
| Sex Distribution | 1 | 2011 | 246 | 0.020 |
Why?
|
| Age Distribution | 1 | 2011 | 251 | 0.020 |
Why?
|
| Drainage | 1 | 2011 | 154 | 0.020 |
Why?
|
| Sex Factors | 1 | 2013 | 962 | 0.020 |
Why?
|
| Acute Disease | 1 | 2012 | 667 | 0.020 |
Why?
|
| Leukemia, Myeloid, Acute | 1 | 2012 | 185 | 0.020 |
Why?
|
| Residence Characteristics | 1 | 2011 | 219 | 0.020 |
Why?
|
| Disease Models, Animal | 1 | 2016 | 2116 | 0.020 |
Why?
|
| Animals | 3 | 2016 | 20218 | 0.020 |
Why?
|
| Diagnosis, Differential | 1 | 2012 | 954 | 0.020 |
Why?
|
| Reproducibility of Results | 1 | 2014 | 1617 | 0.020 |
Why?
|
| United States | 2 | 2013 | 7622 | 0.020 |
Why?
|
| Enema | 1 | 2006 | 13 | 0.020 |
Why?
|
| Risk Assessment | 1 | 2013 | 2019 | 0.020 |
Why?
|
| Equipment Design | 1 | 2007 | 343 | 0.020 |
Why?
|
| Anti-Bacterial Agents | 1 | 2011 | 773 | 0.010 |
Why?
|
| Mediastinal Neoplasms | 1 | 2005 | 19 | 0.010 |
Why?
|
| Foreign-Body Migration | 1 | 2005 | 20 | 0.010 |
Why?
|
| Middle Aged | 1 | 2002 | 17079 | 0.010 |
Why?
|
| Neuroblastoma | 1 | 2005 | 52 | 0.010 |
Why?
|
| Iatrogenic Disease | 1 | 2005 | 60 | 0.010 |
Why?
|
| Insufflation | 1 | 2004 | 9 | 0.010 |
Why?
|
| Radiography | 1 | 2006 | 528 | 0.010 |
Why?
|
| Pressure | 1 | 2004 | 77 | 0.010 |
Why?
|
| Patient Selection | 1 | 2006 | 475 | 0.010 |
Why?
|
| Models, Animal | 1 | 2004 | 228 | 0.010 |
Why?
|
| Swine | 1 | 2004 | 365 | 0.010 |
Why?
|
| Biopsy | 1 | 2004 | 423 | 0.010 |
Why?
|
| Prognosis | 1 | 2006 | 1687 | 0.010 |
Why?
|
| Biomarkers | 1 | 2006 | 1362 | 0.010 |
Why?
|